News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Repros Therapeutics Inc. Reports Fourth Quarter and Year End 2011 Financial Results
March 27, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
THE WOODLANDS, Texas, March 27, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the quarter and year ended December 31, 2011.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
·
5 min read
·
Tristan Manalac
Manufacturing
AbbVie Backs Obesity Push With $380M API Production Expansion Project in Illinois
February 24, 2026
·
2 min read
·
Nick Paul Taylor
Executive appointments
Merck Reorganizes Human Health Work Into Two New Units
February 23, 2026
·
1 min read
·
Annalee Armstrong
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
·
4 min read
·
Annalee Armstrong